Suchen Sie nach Informationen zu Eisai Global Headquarters? Folgen Sie den Links unten, um alle Informationen zu finden, die Sie benötigen, und mehr.
https://us.eisai.com/contact-us#:~:text=Eisai%20Global%20Headquarters%20.%20Eisai%20Co.%2C%20Ltd.%204-6-10,112-8088%20Japan.%20Phone%3A%20%2B81-3-3817-3700.%20Open%20in%20Google%20Maps
https://us.eisai.com/who-we-are/our-locations
Our U.S. Corporate Headquarters in Nutley, NJ, is the nerve center of a fully integrated pharmaceutical business focused on neurology and oncology. Here, we identify major medical challenges that Eisai is uniquely capable of tackling, set priorities, marshal resources and incite innovation. ... Eisai Co., Ltd., a leading global R&D ...
https://www.eisai.com/inquiry/index.html
Alternatively, please call the number below during the following business hours: Monday to Friday, 9 a.m. to 5 p.m. (JST). Contact Form (Global Head Office) Main Switchboard: 81-3-3817-3700. Eisai Group Worldwide. Eisai Group Worldwide.
https://us.eisai.com/contact-us
Eisai Global Headquarters . Eisai Co., Ltd. 4-6-10 Koishikawa, Bunkyo-ku. Tokyo 112-8088 Japan. Phone: +81-3-3817-3700. Open in Google Maps. This is the website of Eisai Inc., a US company. This site is intended for US residents only. The health information contained herein is provided for educational purposes only and is not intended to ...
https://www.eisai.com/index.html
reform of global research and development organization and changes of corporate officers <effective as of july 15, 2022> july 6, 2022. the u.s. fda accepts and grants priority review for eisai’s biologics license application of lecanemab for early alzheimer’s disease under the accelerated approval pathway. june 29, 2022
https://www.eisai.com/company/index.html
Welcome to the Eisai Official Corporate Website About Eisai Page.
Eisai Inc. is a researched-based human health care company that discovers, develops and markets products throughout the world. ... Our Global Pipeline. We're addressing both the causes and symptoms of extremely challenging diseases. Our goal: helping patients whose needs might otherwise be ignored. see what we’re working on now.
https://craft.co/eisai/locations
http://www.eisai.ch/about-eisai/eisai-global/
Eisai employs over 11,000 people worldwide, with operations in the U.S., Asia, Europe, the Middle East and its domestic home market of Japan. Eisai's key areas of commercial focus are neurology and oncology, with an R&D focus in three key areas: Neuroscience including: Epilepsy, Alzheimer's disease, pain and weight loss. Oncology including ...
https://us.eisai.com/who-we-are
Our Global Mission. Our human health care mission, the desire to contribute to patients, is our corporate philosophy and the core of our business. Established in 1992, the hhc philosophy is a common value among all employees worldwide. Spending time with patients and understanding their true needs has become the source of Eisai’s innovation.
https://en.wikipedia.org/wiki/Eisai_%28company%29
History. Nihon Eisai Co. Ltd. was established in 1941. In 1944, merger with Sakuragaoka Research Laboratory resulted in creation of Eisai Co. Ltd. The American subsidiary of the company, Eisai Inc., was established in 1995. On November 25, 1996, Eisai received approval from the United States Food and Drug Administration (USFDA) for Aricept (), a drug discovered in the …
Wir hoffen, dass Sie über die obigen Links alle notwendigen Informationen zu Eisai Global Headquarters gefunden haben.
